Piramal Pharma Limited (NSE:PPLPHARMA)
India · Delayed Price · Currency is INR 136.70
-6.86 (-4.78%)
Mar 30, 2026, 3:30 PM IST
Piramal Pharma Market Cap
Piramal Pharma has a market cap or net worth of 181.3 billion as of March 30, 2026. Its market cap has decreased by -32.12% in one year.
Market Cap
181.30B
Enterprise Value
222.37B
Revenue
88.71B
Ranking
n/a
PE Ratio
n/a
Stock Price
136.70
Market Cap Chart
Since October 19, 2022, Piramal Pharma's market cap has decreased from 226.73B to 181.30B, a decrease of -20.04%. That is a compound annual growth rate of -6.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 181.30B | -20.71% |
| Dec 31, 2025 | 228.67B | -35.22% |
| Dec 31, 2024 | 352.98B | 92.16% |
| Dec 29, 2023 | 183.69B | 34.26% |
| Dec 30, 2022 | 136.81B | -39.66% |
| Oct 19, 2022 | 226.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ipca Laboratories | 402.37B |
| Ajanta Pharma | 350.67B |
| Emcure Pharmaceuticals | 313.33B |
| Gland Pharma | 284.06B |
| Wockhardt | 193.28B |
| Eris Lifesciences | 185.77B |
| NATCO Pharma | 175.29B |
| Alembic Pharmaceuticals | 132.40B |